Promoting Tissue Regeneration Through Modulation of AT2 Receptor Pathway
- Harnessing the AT2 receptor pathway to drive lung tissue repair and counteract fibrotic remodeling in pulmonary diseases, a distinct mechanism from conventional antifibrotics
- Exploring the regenerative potential of C21, an AT2R agonist, to restore alveolar epithelial function and promote vascular integrity
- Advancing a new class of regenerative therapies by targeting endogenous repair pathways, with a focus on improving clinical outcomes through enhanced lung function, symptom relief, and disease modification.